Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00980278 · ClinicalTrials.gov registry record · Phase 1
Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00980278 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 26 participants.
The verdict
NCT00980278, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if one's own bone marrow tissue can help regenerate (grow) bone in the area of the jaw where an implant will be placed. The name of the process is called Bone Repair Cell (BRC) Therapy. A sample of bone marrow tissue will be collected and sent to a laboratory where it will be processed to form more cells. These new cells will then be transplanted in the regenerative site or sinus floor augmentation site. The researchers are testing to see if these cells (BRC) will help form bone indicating. The research will also determine if the implant will be more stable in the area with new bone growth.
Interventions
- PROCEDURE Sinus lift augmentation and dental implant
- BIOLOGICAL Aastrom BRCs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00980278
The ClinicalTrials.gov registry entry for NCT00980278 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sinus lift augmentation and dental implant is the first listed.
NCT00980278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00980278 about?
NCT00980278 is a clinical study titled "Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation". The purpose of this research is to determine if one's own bone marrow tissue can help regenerate (grow) bone in the area of the jaw where an implant will be placed. The name of the process is called Bone Repair Cell (BRC) Therapy. A sample of bone marrow tissue will be collected and sent to a labora...
What is the current status of trial NCT00980278?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2010-03. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00980278?
The interventions under investigation include: Sinus lift augmentation and dental implant (PROCEDURE), Aastrom BRCs (BIOLOGICAL).
Who is sponsoring clinical trial NCT00980278?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.